1. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth, 2nd edition. Gerodontology. 1997;14:33–47.

  2. Turner MD, Ship JA. Dry mouth and its effects on the oral health of elderly people. J Am Dent Assoc. 2007;138:15S–20S.

  3. Eveson JW. Xerostomia. Periodontology 2000. 2008;48:85–91.

  4. Fox PC. J Clin Dent. 2006;17(Spec Iss):27–28.

  5. Dawes C. How much saliva is enough for avoidance of xerostomia? Caries Res. 2004;38:236–240.

  6. GSK data on file.

  7. Thomson WM, et al. The impact of xerostomia on oral-health-related quality of life among younger adults. Health and Quality of Life Outcomes. 2006;4:86.

  8. Sreebny LM. A useful source for the drug-dry mouth relationship. J Dent Educ. 2004;68:6–7.

  9. Sreebny LM. Saliva in health and disease: an appraisal and update. International Dental Journal. 2000;50:140–161.

  10. Hupp WS. Xerostomia. Woman Dentist Jnl. Feb. 8, 2008.

  11. ADA Division of Communications. Do you have dry mouth?JADA. 2002;133:1455.

  12. Scully C. Salivary glands and saliva number 10, drug effects on salivary glands: dry mouth. Oral Diseases. 2003;9:165–176.

  1. von Bültzingslöwen I, et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(Suppl 1):S57.e1–S57.e15.

  2. Vernillo AT. Dental considerations for the treatment of patients with diabetes mellitus. JADA. 2003;134:24S–33S.

  3. Porter SR, et al. An update of the etiology and management of xerostomia. Oral Surg, Oral Med, Oral Pathol. 2004;97:28–46.

  4. e-CPS. Accessed January 2011 at

  5. GSK data on file.

BIOTÈNE is a registered trademark of the GlaxoSmithKline group of companies.

© 2013 GlaxoSmithKline

This site is intended for Canadian residents only.

Copyright © 2016 GSK. All rights reserved.